This is a $3,902,011.00 Firm Fixed Price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Boundless Science, LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of a "Novel Blood Oxygenation Device to Save Warriors on the Battlefield" to address Acute Respiratory Distress Syndrome (ARDS). This builds on Boundless Science's prior SBIR Phase I contract from the Army Medical Command to design a Combat Oxygenation Device. The contract has a total small business set-aside designation, highlighting DARPA's focus on fostering innovation within the small business sector. The contract's ultimate completion date is August 2, 2026.
Generated 1/31/25, 9:01 AM